Ropeginterferon Alfa-2B: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ropeginterferon Alfa-2B. Educational only — not medical advice.
Labeled uses
BESREMi is indicated for the treatment of adults with polycythemia vera.
Source: FDA labeling via NIH DailyMed (set 9583405d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.